Access Bio

950130 · KOSDAQ · Health Care · SMALL CAP

Updated terms.

Access Bio updated the disclosed terms of an acquisition of RF Bio Co., Ltd., now worth US$38.7M.

M&A([Amended] Decision to acquire shares/equity in another company)· FILED 2026-04-15· RCEPT 20260415900576

US$38.7MDeal value
7.7%vs. company assets

Converted at 1 USD ≈ ₩1,474.06 (filing-date rate, 2026-04-15 close)

What happened

Access Bio updated the disclosed terms of an acquisition of RF Bio Co., Ltd., now worth US$38.7M.

For context, this deal is worth about 7.7% of the company's own total assets.

TargetRF Bio Co., Ltd.
Deal valueUS$38.7M
vs. company assets7.7%
Filed2026-04-15, [Amended] Decision to acquire shares/equity in another company
SourceDART rcept 20260415900576 → open original filing

Versions of this filing

  1. 2026-01-19Original
  2. 2026-03-27Amendment 1
  3. 2026-04-15Amendment 2 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-04-15 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.